Gail Taylor
Family Medicine · Midlothian, VANPI 1548318702
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Johnson & Johnson at 34.0% of the total. Reporting peaked in 2019 at $487 and has fallen 56.5% since, to $212 in 2023.
Across 100 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$654
- Melinta Therapeutics, LLC$211
- Paratek Pharmaceuticals, Inc.$182
- Viiv Healthcare Company$173
- Merck$147
- Theratechnologies Inc.$103
- plus $453 from 13 others
What the payments were for
- Food & beverage$1,923100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 28 | $654 |
| Melinta Therapeutics, LLC | 12 | $211 |
| Paratek Pharmaceuticals, Inc. | 9 | $182 |
| Viiv Healthcare Company | 7 | $173 |
| Merck | 9 | $147 |
| Theratechnologies Inc. | 6 | $103 |
| Tetraphase Pharmaceuticals, Inc. | 6 | $102 |
| Novo Nordisk | 6 | $84 |
| Lilly USA, LLC | 6 | $68 |
| Shionogi Inc | 1 | $42 |
| GSK | 2 | $34 |
| Boston Scientific | 1 | $26 |
| Nabriva Therapeutics, PLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Vyera Pharmaceuticals, LLC | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$1,923 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valsartan | 21 | $745 |
| Rosuvastatin Calcium | 42 | $641 |
| Atorvastatin Calcium | 37 | $422 |
| Omeprazole | 24 | $350 |
| Metoprolol Succinate | 28 | $256 |
| Losartan Potassium | 22 | $214 |
| Levothyroxine Sodium | 19 | $200 |
| Pantoprazole Sodium | 17 | $196 |
| Amlodipine Besylate | 39 | $191 |
| Lisinopril | 38 | $173 |
| Metformin Hcl | 25 | $151 |
| Montelukast Sodium | 18 | $111 |
| Buspirone Hcl | 12 | $82 |
| Sertraline Hcl | 12 | $68 |
| Trazodone Hcl | 18 | $55 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Midlothian
- Donald SandersMidlothian$15K
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.